Filed: 11/14/2024ACC: 0001583977-24-000006
📋 What this filing means
CORMORANT ASSET MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 45 equity positions with a total reported market value of $1.89B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
45
Positions
$1.89B
Total AUM (reported)
72.59M
Total Shares
Allocation by class
COM$1.00B53.2%
CLASS A ORD$428.28M22.7%
COM NEW$165.57M8.8%
COMMON STOCK$104.39M5.5%
SPONSORED ADS$65.50M3.5%
ORDINARY SHARES$44.97M2.4%
COM PAR $.01$36.50M1.9%
Portfolio Concentration
Top 3$646.93M34.3%
4–10$465.94M24.7%
11–25$546.40M29.0%
Rest$226.49M12.0%
Top 3 weight
34.3%
Top 10 weight
59.0%
Voting Authority Distribution
Total shares with voting rights: 72.59M
Sole
Full voting authority
72.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other45
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings45
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares8.49M
TypeSH
Market value$428.28M
22.71%
Sole
8.49M
Shared
0.00
None
0.00
VAXCYTE INC
DFNDShares1M
TypeSH
Market value$114.27M
6.06%
Sole
1M
Shared
0.00
None
0.00
ARCELLX INC
DFNDShares1.25M
TypeSH
Market value$104.39M
5.54%
Sole
1.25M
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
DFNDShares2.79M
TypeSH
Market value$93.01M
4.93%
Sole
2.79M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
DFNDShares3.41M
TypeSH
Market value$90.92M
4.82%
Sole
3.41M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
DFNDShares8.32M
TypeSH
Market value$66.52M
3.53%
Sole
8.32M
Shared
0.00
None
0.00
RAPPORT THERAPEUTICS INC
DFNDShares2.94M
TypeSH
Market value$60.23M
3.19%
Sole
2.94M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
DFNDShares1.10M
TypeSH
Market value$56.21M
2.98%
Sole
1.10M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares870K
TypeSH
Market value$50.06M
2.65%
Sole
870K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
DFNDShares2.38M
TypeSH
Market value$49.00M
2.60%
Sole
2.38M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
DFNDShares1.05M
TypeSH
Market value$48.23M
2.56%
Sole
1.05M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
DFNDShares1.05M
TypeSH
Market value$47.70M
2.53%
Sole
1.05M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares1.86M
TypeSH
Market value$47.31M
2.51%
Sole
1.86M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
DFNDShares2.47M
TypeSH
Market value$41.00M
2.17%
Sole
2.47M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
DFNDShares2.56M
TypeSH
Market value$40.96M
2.17%
Sole
2.56M
Shared
0.00
None
0.00
MERUS N V
DFNDShares740K
TypeSH
Market value$36.97M
1.96%
Sole
740K
Shared
0.00
None
0.00
CG ONCOLOGY INC
DFNDShares975K
TypeSH
Market value$36.79M
1.95%
Sole
975K
Shared
0.00
None
0.00
INSMED INC
DFNDShares500K
TypeSH
Market value$36.50M
1.94%
Sole
500K
Shared
0.00
None
0.00
BIOMEA FUSION INC
DFNDShares3.57M
TypeSH
Market value$36.07M
1.91%
Sole
3.57M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
DFNDShares400K
TypeSH
Market value$35.95M
1.91%
Sole
400K
Shared
0.00
None
0.00
BIOAGE LABS INC
DFNDShares1.63M
TypeSH
Market value$33.89M
1.80%
Sole
1.63M
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
DFNDShares2.91M
TypeSH
Market value$30.40M
1.61%
Sole
2.91M
Shared
0.00
None
0.00
PHARVARIS N V
DFNDShares1.47M
TypeSH
Market value$27.16M
1.44%
Sole
1.47M
Shared
0.00
None
0.00
ABIVAX SA
DFNDShares2.13M
TypeSH
Market value$24.54M
1.30%
Sole
2.13M
Shared
0.00
None
0.00
ALUMIS INC
DFNDShares2.15M
TypeSH
Market value$22.93M
1.22%
Sole
2.15M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 8.49M | SH | $428.28M 22.71% | 8.49M | 0.00 | 0.00 |
VAXCYTE INCDFND | COM | 1M | SH | $114.27M 6.06% | 1M | 0.00 | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 1.25M | SH | $104.39M 5.54% | 1.25M | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INDFND | COM | 2.79M | SH | $93.01M 4.93% | 2.79M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCDFND | COM | 3.41M | SH | $90.92M 4.82% | 3.41M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCDFND | COM NEW | 8.32M | SH | $66.52M 3.53% | 8.32M | 0.00 | 0.00 |
RAPPORT THERAPEUTICS INCDFND | COM | 2.94M | SH | $60.23M 3.19% | 2.94M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INDFND | COM | 1.10M | SH | $56.21M 2.98% | 1.10M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 870K | SH | $50.06M 2.65% | 870K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSDFND | COM NEW | 2.38M | SH | $49.00M 2.60% | 2.38M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCDFND | COM | 1.05M | SH | $48.23M 2.56% | 1.05M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCDFND | COM | 1.05M | SH | $47.70M 2.53% | 1.05M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 1.86M | SH | $47.31M 2.51% | 1.86M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 2.47M | SH | $41.00M 2.17% | 2.47M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCDFND | SPONSORED ADS | 2.56M | SH | $40.96M 2.17% | 2.56M | 0.00 | 0.00 |
MERUS N VDFND | COM | 740K | SH | $36.97M 1.96% | 740K | 0.00 | 0.00 |
CG ONCOLOGY INCDFND | COM | 975K | SH | $36.79M 1.95% | 975K | 0.00 | 0.00 |
INSMED INCDFND | COM PAR $.01 | 500K | SH | $36.50M 1.94% | 500K | 0.00 | 0.00 |
BIOMEA FUSION INCDFND | COM | 3.57M | SH | $36.07M 1.91% | 3.57M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCDFND | COM | 400K | SH | $35.95M 1.91% | 400K | 0.00 | 0.00 |
BIOAGE LABS INCDFND | COM | 1.63M | SH | $33.89M 1.80% | 1.63M | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIDFND | CL A ORD SHS | 2.91M | SH | $30.40M 1.61% | 2.91M | 0.00 | 0.00 |
PHARVARIS N VDFND | COM | 1.47M | SH | $27.16M 1.44% | 1.47M | 0.00 | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 2.13M | SH | $24.54M 1.30% | 2.13M | 0.00 | 0.00 |
ALUMIS INCDFND | COM | 2.15M | SH | $22.93M 1.22% | 2.15M | 0.00 | 0.00 |
Page 1 of 2